Abstract
Cisplatin (CDDP) is one of the most effective chemotherapeutic agent used in the treatment of many kind of solid tumors. Its primary side effect is nephrotoxicity. The aim of this study to investigate the effects of taurine on cisplatin-induced acute nephrotoxicity. A single intraperitoneal injection of CDDP (15 mg/kg, or 25 mg/kg) deteriorated the kidney functions as reflected by histopathological changes. Histopathological changes were observed in all cisplatin groups. In the cisplatin group, oxidative stress was evident in the cisplatin group by observing an increase in 8-OHdG expression, an indicator of oxidative DNA damage. CDDP also resulted to an increase in CD68 expression in the renal tissues of CDDP groups. Taurine transporter (TauT) was down-regulated, and p53 was up-regulated in renal tissues as indicated by immunohistochemical analysis. Administration with taurine prior to a cisplatin injection was able to protect against deterioration of kidney function, to abrogate the decline in anti-oxidants and to suppress the increase in DNA damage. Moreover, taurine inhibited p53 activation and improved the pathological changes induced by cisplatin. This study demonstrates the protective effects of taurine in attenuating the expression of pro-inflammatory mediators and in improving antioxidant capacity in the kidney of cisplatin-injected rats. Thus, taurine could be a beneficial dietary supplement to attenuate cisplatin induced nephrotoxicity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- 8-OHdG:
-
8-Hydroxy-2′-deoxyguanosine
- CDDP:
-
Cis-diammine dichloroplatinum II (cisplatin)
- TauT:
-
Taurine transporter
References
Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23(5):460–464. S0270929503000895 [pii]
Camano S, Lazaro A, Moreno-Gordaliza E, Torres AM, de Lucas C, Humanes B, Lazaro JA, Milagros Gomez-Gomez M, Bosca L, Tejedor A (2010) Cilastatin attenuates cisplatin-induced proximal tubular cell damage. J Pharmacol Exp Ther 334(2):419–429. doi:10.1124/jpet.110.165779. jpet.110.165779 [pii]
Chirino YI, Pedraza-Chaverri J (2009) Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 61(3):223–242. doi:10.1016/j.etp.2008.09.003. S0940-2993(08)00138-3 [pii]
Davis CA, Nick HS, Agarwal A (2001) Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12(12):2683–2690
Faubel S, Lewis EC, Reznikov L, Ljubanovic D, Hoke TS, Somerset H, Oh DJ, Lu L, Klein CL, Dinarello CA, Edelstein CL (2007) Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther 322(1):8–15. doi:10.1124/jpet.107.119792. jpet.107.119792 [pii]
Fontanelli R, Spatti G, Raspagliesi F, Zunino F, Di Re F (1992) A preoperative single course of high-dose cisplatin and bleomycin with glutathione protection in bulky stage IB/II carcinoma of the cervix. Ann Oncol 3(2):117–121
Francescato HD, Costa RS, Scavone C, Coimbra TM (2007) Parthenolide reduces cisplatin-induced renal damage. Toxicology 230(1):64–75. doi:10.1016/j.tox.2006.10.025. S0300-483X(06)00638-X [pii]
Giri SN, Gurujeyalakshmi G, Wang Y (2000) Suppression of bleomycin-induced increased production of nitric oxide and NF-kB activation by treatment with taurine and niacin. Adv Exp Med Biol 483:545–561. doi:10.1007/0-306-46838-7_59
Han X, Chesney RW (2010) Stress-responsive gene TauT and acute kidney injury. J Biomed Sci 17(Suppl 1):S28. doi:10.1186/1423-0127-17-S1-S28. 1423-0127-17-S1-S28 [pii]
Han X, Patters AB, Jones DP, Zelikovic I, Chesney RW (2006) The taurine transporter: mechanisms of regulation. Acta Physiol (Oxford) 187(1–2):61–73. doi:10.1111/j.1748-1716.2006.01573.x. APS1573 [pii]
Hansen SH, Andersen ML, Birkedal H, Cornett C, Wibrand F (2006) The important role of taurine in oxidative metabolism. Adv Exp Med Biol 583:129–135
Hosokawa Y, Matsumoto A, Oka J, Itakura H, Yamaguchi K (1990) Isolation and characterization of a cDNA for rat liver cysteine dioxygenase. Biochem Biophys Res Commun 168(2):473–478. 0006-291X(90)92345-Z [pii]
Ideishi M, Miura S, Sakai T, Sasaguri M, Misumi Y, Arakawa K (1994) Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. J Hypertens 12(6):653–661
Kim C, Choi HS, Kim JW (2006) Taurine chloramine inhibits the production of nitric oxide and superoxide anion by modulating specific mitogen-activated protein kinases. Adv Exp Med Biol 583:493–498
Lambert IH, Kristensen DM, Holm JB, Mortensen OH (2014) Physiological role of taurine--from organism to organelle. Acta Physiol (Oxford) 213(1):191–212. doi:10.1111/apha.12365
Loehrer PJ, Einhorn LH (1984) Drugs five years later. Cisplatin Ann Intern Med 100(5):704–713
Ma N, Aoki E, Semba R (1994) An immunohistochemical study of aspartate, glutamate, and taurine in rat kidney. J Histochem Cytochem 42(5):621–626
Mochizuki T, Satsu H, Shimizu M (2005) Signaling pathways involved in tumor necrosis factor alpha-induced upregulation of the taurine transporter in Caco-2 cells. FEBS Lett 579(14):3069–3074. doi:10.1016/j.febslet.2005.04.063. S0014-5793(05)00540-5 [pii]
Mozaffari MS, Patel C, Abdelsayed R, Schaffer SW (2006) Accelerated NaCl-induced hypertension in taurine-deficient rat: role of renal function. Kidney Int 70(2):329–337. doi:10.1038/sj.ki.5001503. S0085-2538(15)51923-6 [pii]
Ozols RF (1995) Current status of chemotherapy for ovarian cancer. Semin Oncol 22(5 Suppl 12):61–66
Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73(9):994–1007. doi:10.1038/sj.ki.5002786. 5002786 [pii]
Panici PB, Greggi S, Scambia G, Ragusa G, Baiocchi G, Battaglia F, Coronetta F, Mancuso S (1991) High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: a preliminary report. Gynecol Oncol 41(3):212–216. 0090-8258(91)90310-2 [pii]
Perez-Rojas JM, Guerrero-Beltran CE, Cruz C, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Pedraza-Chaverri J (2011) Preventive effect of tert-butylhydroquinone on cisplatin-induced nephrotoxicity in rats. Food Chem Toxicol 49(10):2631–2637. doi:10.1016/j.fct.2011.07.008. S0278-6915(11)00331-0 [pii]
Ries F, Klastersky J (1986) Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 8(5):368–379. S0272638686001129 [pii]
Sato S, Yamate J, Saito T, Hosokawa T, Saito S, Kurasaki M (2002) Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin. Naunyn Schmiedeberg’s Arch Pharmacol 365(4):277–283. doi:10.1007/s00210-001-0524-8
Schaffer SW, Lombardini JB, Azuma J (2000) Interaction between the actions of taurine and angiotensin II. Amino Acids 18(4):305–318
Townsend DM, Deng M, Zhang L, Lapus MG, Hanigan MH (2003) Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 14(1):1–10
Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334(2):115–124. doi:10.1097/MAJ.0b013e31812dfe1e. 00000441-200708000-00006 [pii]
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media B.V.
About this paper
Cite this paper
Tsunekawa, M., Wang, S., Kato, T., Yamashita, T., Ma, N. (2017). Taurine Administration Mitigates Cisplatin Induced Acute Nephrotoxicity by Decreasing DNA Damage and Inflammation: An Immunocytochemical Study. In: Lee, DH., Schaffer, S.W., Park, E., Kim, H.W. (eds) Taurine 10. Advances in Experimental Medicine and Biology, vol 975. Springer, Dordrecht. https://doi.org/10.1007/978-94-024-1079-2_55
Download citation
DOI: https://doi.org/10.1007/978-94-024-1079-2_55
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-024-1077-8
Online ISBN: 978-94-024-1079-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)